$1.39
0.096.92%
At Close: -
$1.42
0.032.16%
After Hours: 7:35 PM EDT
15 minutes delayed
Comments
Loading...
Adaptimmune Therapeutics
ADAPNASDAQ
Adaptimmune Therapeutics (NASDAQ:ADAP) Stock, Earnings Estimates, EPS, And Revenue
Adaptimmune Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 7
EPS Estimate
$-0.080
Quarterly Revenue Estimate
$38.5M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$18.4M
Analyze the earnings history of Adaptimmune Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADAP | Adaptimmune Therapeutics | -$0.12 | -$0.08 | — | — | $5.13M | $38.48M | — | — | 08/07/2024 | Get Alert |
| ADAP | Adaptimmune Therapeutics | $0.00 | -$0.10 | -$0.18 | -80.00% | $47.60M | $10.73M | $5.68M | -47.08% | 05/15/2024 | Get Alert |
| ADAP | Adaptimmune Therapeutics | -$0.18 | -$0.10 | -$0.24 | -140.00% | $11.03M | $20.47M | $231.00K | -98.87% | 03/06/2024 | Get Alert |
| ADAP | Adaptimmune Therapeutics | -$0.24 | -$0.15 | -$0.18 | -20.00% | $7.01M | $10.28M | $7.32M | -28.80% | 11/08/2023 | Get Alert |
| ADAP | Adaptimmune Therapeutics | -$0.05 | -$0.13 | -$0.12 | 7.69% | $5.54M | $8.78M | $5.13M | -41.57% | 08/09/2023 | Get Alert |
| ADAP | Adaptimmune Therapeutics | -$0.05 | -$0.14 | $0.00 | 100.00% | $3.58M | $4.93M | $47.60M | 865.54% | 05/12/2023 | Get Alert |
| ADAP | Adaptimmune Therapeutics | -$0.04 | -$0.25 | -$0.18 | 28.00% | $1.42M | $4.12M | $11.03M | 167.67% | 03/06/2023 | Get Alert |
| ADAP | Adaptimmune Therapeutics | -$0.30 | -$0.24 | -$0.24 | 0.00% | $1.20M | $4.04M | $7.01M | 73.44% | 11/08/2022 | Get Alert |
| ADAP | Adaptimmune Therapeutics | -$0.24 | -$0.25 | -$0.28 | -12.00% | $3.10M | $6.00M | $5.54M | -7.70% | 08/04/2022 | Get Alert |
| ADAP | Adaptimmune Therapeutics | -$0.04 | -$0.22 | -$0.32 | -45.45% | $434.00K | $3.29M | $3.58M | 8.66% | 05/09/2022 | Get Alert |
| ADAP | Adaptimmune Therapeutics | -$0.24 | $0.14 | -$0.25 | -278.57% | $1.50M | $96.45M | $1.42M | -98.53% | 03/14/2022 | Get Alert |
| ADAP | Adaptimmune Therapeutics | -$0.24 | -$0.26 | -$0.30 | -15.38% | $1.19M | $1.37M | $1.20M | -12.19% | 11/04/2021 | Get Alert |
| ADAP | Adaptimmune Therapeutics | -$0.24 | -$0.24 | -$0.24 | 0.00% | $502.00K | $1.36M | $3.10M | 127.57% | 08/09/2021 | Get Alert |
| ADAP | Adaptimmune Therapeutics | -$0.04 | -$0.25 | -$0.24 | 4.00% | $761.00K | $1.83M | $434.00K | -76.28% | 05/06/2021 | Get Alert |
| ADAP | Adaptimmune Therapeutics | -$0.05 | -$0.23 | -$0.24 | -4.35% | $728.00K | $1.98M | $1.50M | -24.14% | 02/25/2021 | Get Alert |
| ADAP | Adaptimmune Therapeutics | -$0.06 | -$0.25 | -$0.24 | 4.00% | $237.00K | $870.00K | $1.19M | 37.13% | 11/05/2020 | Get Alert |
| ADAP | Adaptimmune Therapeutics | -$0.07 | -$0.23 | -$0.24 | -4.35% | $157.00K | $930.00K | $502.00K | -46.02% | 08/06/2020 | Get Alert |
| ADAP | Adaptimmune Therapeutics | -$0.04 | -$0.25 | -$0.04 | 84.00% | $0.00 | $23.29M | $761.00K | -96.73% | 05/14/2020 | Get Alert |
| ADAP | Adaptimmune Therapeutics | $0.01 | -$0.32 | -$0.05 | 84.38% | $40.79M | $1.52M | $728.00K | -52.11% | 02/27/2020 | Get Alert |
| ADAP | Adaptimmune Therapeutics | $0.01 | -$0.31 | -$0.06 | 80.65% | $40.79M | $1.48M | $237.00K | -83.99% | 11/06/2019 | Get Alert |
| ADAP | Adaptimmune Therapeutics | -$0.08 | -$0.33 | -$0.07 | 78.79% | $9.04M | $2.00M | $157.00K | -92.15% | 08/01/2019 | Get Alert |
Adaptimmune Therapeutics (ADAP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-15 | $-0.18 | $-0.10 | -80.0 % |
| Dec 2023 | 2024-03-06 | $-0.24 | $-0.10 | -140.0 % |
| Sep 2023 | 2023-11-08 | $-0.18 | $-0.15 | -20.0 % |
| Jun 2023 | 2023-08-09 | $-0.12 | $-0.13 | 7.69 % |
Adaptimmune Therapeutics (ADAP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-15 | $5.68M | $10.73M | -47.1 % |
| Dec 2023 | 2024-03-06 | $231.00K | $20.47M | -98.9 % |
| Sep 2023 | 2023-11-08 | $7.32M | $10.28M | -28.8 % |
| Jun 2023 | 2023-08-09 | $5.13M | $8.78M | -41.6 % |
FAQ
When is Adaptimmune Therapeutics (NASDAQ:ADAP) reporting earnings?
Adaptimmune Therapeutics (ADAP) is scheduled to report earnings on August 7, 2024. The last reported earnings were for reported on May 15, 2024 for Q1.
What were the latest earnings per share (EPS) for Adaptimmune Therapeutics (NASDAQ:ADAP)?
The Actual EPS was $-0.18, which missed the estimate of $-0.10.
What were Adaptimmune Therapeutics’s (NASDAQ:ADAP) revenues?
The Actual Revenue was $5.7M, which missed the estimate of $10.7M.
Browse earnings estimates, EPS, and revenue on all stocks.